Your browser doesn't support javascript.
loading
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer.
Vyfhuis, Melissa A L; Bhooshan, Neha; Burrows, Whitney M; Turner, Michelle; Suntharalingam, Mohan; Donahue, James; Nichols, Elizabeth M; Feliciano, Josephine; Bentzen, Søren M; Badiyan, Shahed; Carr, Shamus R; Friedberg, Joseph; Simone, Charles B; Edelman, Martin J; Feigenberg, Steven J; Mohindra, Pranshu.
Afiliação
  • Vyfhuis MAL; Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland.
  • Bhooshan N; Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland.
  • Burrows WM; Department of Surgery, Division of Thoracic Surgery, University of Maryland School of Medicine, Baltimore, Maryland.
  • Turner M; Department of Medicine, Division of Hematology/Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Suntharalingam M; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Donahue J; Department of Surgery, Division of Thoracic Surgery, University of Maryland School of Medicine, Baltimore, Maryland.
  • Nichols EM; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Feliciano J; Department of Medicine, Division of Hematology/Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Bentzen SM; Department of Epidemiology and Public Health, Biostatistics and Bioinformatics Division, University of Maryland School of Medicine, Baltimore, Maryland.
  • Badiyan S; Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland.
  • Carr SR; Department of Surgery, Division of Thoracic Surgery, University of Maryland School of Medicine, Baltimore, Maryland.
  • Friedberg J; Department of Surgery, Division of Thoracic Surgery, University of Maryland School of Medicine, Baltimore, Maryland.
  • Simone CB; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Edelman MJ; Department of Medicine, Division of Hematology/Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Feigenberg SJ; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Mohindra P; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
Adv Radiat Oncol ; 2(3): 259-269, 2017.
Article em En | MEDLINE | ID: mdl-29114590

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article